Stay updated on Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page.

Latest updates to the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded a consolidated Locations section listing Illinois, Michigan, New York, and North Carolina, replacing the previous separate state location subsections; removed the state-specific location subsections and updated the page revision from v3.3.2 to v3.3.3.SummaryDifference0.5%

- Check48 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; no changes to study details, eligibility criteria, outcomes, or safety information were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page revision updated from v3.2.0 to v3.3.1. No substantive changes to the study details, eligibility criteria, or outcomes are evident.SummaryDifference0.1%

- Check63 days agoChange DetectedRemoved the government funding lapse notice banner from the page, removing an operational alert without altering trial data or eligibility information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check77 days agoChange DetectedThe page content and layout appear unchanged between screenshots, with no additions or removals affecting the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page.